# OnCo record ixazomib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ixazomib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ixazomib" ;
  schema:name "Ixazomib"@en ;
  schema:description "Ixazomib (Ninlaro) is the first oral proteasome inhibitor for multiple myeloma, enabling an all-oral triplet with lenalidomide and dexamethasone."@en ;
  schema:url <https://onco.cc/drugs/ixazomib/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Ixazomib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q20948663> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ixazomib> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:modality "Oral proteasome inhibitor (boronate)" ;
  schema:alternateName "Ninlaro" ;
  onco:approval "US 2015: Multiple myeloma after ≥1 prior therapy, with lenalidomide and dexamethasone", "EU 2016: Same" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:companies <https://onco.cc/companies/takeda/> ;
  onco:trials <https://onco.cc/trials/nct04068597/> .